Work

The VITAL Trial: Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of acute Myeloid Leukemia

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-131520

Authors: Stephen A Strickland, Nikolai A. Podoltsev, Sanjay R Mohan, Amer M. Zeidan, Merrida A Childress, Gregory D Ayers, Michael T Byrne, Steven D. Gore, Robert K. Stuart, Michael R. Savona

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Yale Cancer Center, Yale University, Medical University of South Carolina, MUSC Hollings Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990660029

Cites:

Cited by: 11

Related to: 10